Verve Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Verve Therapeutics, Inc.‘s stocks are currently a part of 64 hedge funds’ portfolios, which represents 71.73% of the total amount of its stocks outstanding. This makes up a total of 38.75M shares of Verve Therapeutics, Inc.. Compared to the previous quarter, the number fell by -38.12% or -23.86M shares fewer. As for the holding position changes, 34.38% (22) of current hedge fund investors increased the number of shares held, 29.69% (19) of current holders sold a part of the shares held, and 17.19% (11) closed the holdings completely. 8 hedge funds are new holders of Verve Therapeutics, Inc. stock in Q1 2023, it is 12.5% of total holders.
Hedge funds holding Verve Therapeutics (Q2 2021 – Q1 2023)
| Q2 2021 | 69 |
|---|---|
| Q3 2021 | 73 |
| Q4 2021 | 91 |
| Q1 2022 | 90 |
| Q2 2022 | 96 |
| Q3 2022 | 120 |
| Q4 2022 | 119 |
| Q1 2023 | 64 |
Hedge funds changes in Verve Therapeutics positions (Q2 2021 – Q1 2023)
| Q2 2021 | 69 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2021 | 34 | 16 | 13 | 30 | -20 |
| Q4 2021 | 28 | 32 | 18 | 10 | 3 |
| Q1 2022 | 18 | 39 | 22 | 19 | -8 |
| Q2 2022 | 24 | 31 | 21 | 17 | 3 |
| Q3 2022 | 42 | 55 | 15 | 18 | -10 |
| Q4 2022 | 26 | 47 | 29 | 25 | -8 |
| Q1 2023 | 8 | 22 | 19 | 11 | 4 |
Hedge funds changes in Verve Therapeutics stock options (Q2 2021 – Q1 2023)
| Q2 2021 | 0 | 0 |
|---|---|---|
| Q3 2021 | 0 | 0 |
| Q4 2021 | 501,000 | 745,000 |
| Q1 2022 | 212,000 | 1,248,000 |
| Q2 2022 | 3,873,000 | 201,000 |
| Q3 2022 | 15,987,000 | 4,260,000 |
| Q4 2022 | 8,997,255 | 1,149,040 |
| Q1 2023 | 360,510,000 | 0 |